A case for genotype-guided de-escalation of antiplatelet therapy after percutaneous coronary angioplasty

Lignende værker

• CYP2C19 Genotype‐Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings
  af: Amber L. Beitelshees, et al.
  Udgivet: (2022-02-01)
• Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention
  af: Cavallari, Larisa H., et al.
  Udgivet: (2018)
• CYP2C19 Genotype-Guided Antiplatelet Therapy and Thirty-Day Outcomes after Percutaneous Coronary Intervention
  af: Williams, Alexis K., et al.
  Udgivet: (2019)
• Clinical Outcomes and Sustainability of Using CYP2C19 Genotype-guided Antiplatelet Therapy after Percutaneous Coronary Intervention
  af: Lee, Craig R., et al.
  Udgivet: (2018)
• Impact of the CYP2C19*17 allele on outcomes in patients receiving genotype-guided antiplatelet therapy after percutaneous coronary intervention
  af: Lee, Craig R., et al.
  Udgivet: (2020)